%D8%A3%D9%86%D8%A7%D9%86%D8%AF%D8%A7%D9%85%D9%8A%D8%AF%D8%A2%D9%86%D8%A7%D9%86%D8%AF%D8%A7%D9%85%DB%8C%D8%AFCategory:AnandamideAnandamidAnandamidAnandamideAnandamida%D8%A2%D9%86%D8%A7%D9%86%D8%AF%D8%A7%D9%85%DB%8C%D8%AFAnandamidiAnandamide%D7%90%D7%A0%D7%90%D7%A0%D7%93%D7%9E%D7%99%D7%93AnandamidAnandamide%E3%82%A2%E3%83%8A%E3%83%B3%E3%83%80%E3%83%9F%E3%83%89%EC%95%84%EB%82%9C%EB%8B%A4%EB%AF%B8%EB%93%9CAnandamidumAnandamideAnandamidAnandamid%D0%90%D0%BD%D0%B0%D0%BD%D0%B4%D0%B0%D0%BC%D0%B8%D0%B4AnandamidAnandamidAnandamid%E0%AE%86%E0%AE%A9%E0%AE%A8%E0%AF%8D%E0%AE%A4%E0%AE%AE%E0%AF%88%E0%AE%9F%E0%AF%81%D0%90%D0%BD%D0%B0%D0%BD%D0%B4%D0%B0%D0%BC%D1%96%D0%B4%D8%A2%D9%86%D8%A7%D9%86%DA%88%D8%A7%D9%85%DB%8C%DA%88AnandamideQ410228%E8%8A%B1%E7%94%9F%E5%9B%9B%E7%83%AF%E4%B9%99%E9%86%87%E8%83%BA
about
Calcium voltage-gated channel subunit alpha1 GCalcium voltage-gated channel subunit alpha1 HCalcium voltage-gated channel subunit alpha1 IGlycine receptor alpha 1G protein-coupled receptor 18G protein-coupled receptor 55Potassium voltage-gated channel subfamily A member 2Potassium two pore domain channel subfamily K member 3Potassium two pore domain channel subfamily K member 9Cannabinoid receptor 2Cannabinoid receptor 1Transient receptor potential cation channel subfamily V member 1Transient receptor potential cation channel subfamily M member 8
P129
Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugsThe insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependentN-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivoSupersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseAnandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashionCannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaThe endocannabinoid system as a target for the treatment of cannabis dependenceThe elmiric acids: biologically active anandamide analogsIdentification of intracellular carriers for the endocannabinoid anandamideA biosynthetic pathway for anandamideAnandamide and vanilloid TRPV1 receptorsLack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitroAnandamide administration into the ventromedial hypothalamus stimulates appetite in ratsAM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic painEvidence against the presence of an anandamide transporterAnandamide uptake by synaptosomes from human, mouse and rat brain: inhibition by glutamine and glutamateQuantification of anandamide content in animal cells and tissues: the normalization makes the differenceAmygdala FAAH and anandamide: mediating protection and recovery from stressExploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporterThe endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathwaysRelation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriageAnandamide inhibits the DOI-induced head-twitch response in miceThe endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungsMolecular characterization of a phospholipase D generating anandamide and its congeners(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stabilityMolecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteinsAnandamide may mediate sleep inductionModulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamideEnzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonistA re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neuronsAnandamide modulates sleep and memory in ratsMethyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidaseOpposite effects of anandamide and N-arachidonoyl dopamine in the regulation of prostaglandin E and 8-iso-PGF formation in primary glial cellsThe endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamidePalmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cellsEffects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamideAnandamide activates peripheral nociceptors in normal and arthritic rat knee jointsStructure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferensA possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus
P921
Q21102123-33A94E08-5B74-4C2C-92E7-2E64EA691E8AQ21102129-9ADAD4C9-BFC6-4AC7-972F-F8993F61F7E5Q21102152-A81020CA-D949-4F3D-896C-1D9EFE389180Q21103155-518B266B-4342-425B-AFCF-A34C2FB0B096Q21110922-506055F4-B618-498D-BC5E-811788066F2CQ21110942-11E184B2-4E5E-4CDD-9650-3E6CBFE3640DQ21111879-9D0C0B3C-9359-48F6-94D6-AA64D42EEB77Q21119816-2DF2315A-FABC-413F-A3E6-DDA4D9FD8B45Q21119848-8D9495F2-12E5-4523-BB66-8DF655D362DAQ21150595-4DB20F32-38D8-4A29-8232-DC5AA1250892Q21201294-BB4A4E95-6582-4EE3-A7A4-D0D257C56F90Q413209-5B86914E-3B72-46B4-B21D-F03E847C9B63Q7671495-14729FD7-095E-4D8E-84A2-B904EA5A47C2
P129
Q21090833-EEA4FC6B-43B9-43EA-9D82-4FEE7FF5B096Q21092130-1EDF3953-8966-4CC0-A50F-BEC26BCA50F1Q24532188-38C7A09F-D42B-48C3-B7D1-03296449DA7AQ24555807-BA08A226-EB86-44B1-BA63-34558D0B08D3Q24598965-1B59E370-0C1D-4EE2-8390-C64B4C7E2647Q24607361-5354724C-3C00-4B6A-A7AF-331C7AFE15ADQ24648135-209BBFF7-B0A5-47C6-99D5-FF02D048AE01Q24650559-0A4D0EAD-E818-44DB-AB34-8FD89C056231Q24658373-8BE88B4F-ECD8-4949-9526-9C25E4B033B6Q24671032-87AF9AF3-DB90-4B96-8DE8-12D9FA643673Q24672354-CB2FCF2E-4801-458B-AB3C-5271B390E136Q24673383-D2EB6BFD-4D48-464B-9A31-1F1658F4172BQ24673420-58221EEE-258C-45BF-BE7A-56D53B94893BQ24675554-90B958BA-F91B-498F-B584-3234013DE31EQ24683153-97B503CF-96FC-4FBF-A78F-001969F031EAQ24793780-2D23714A-614A-4693-BF9E-7291B41F0ED6Q24793873-9B17AF9D-ABD9-4D6E-949A-8BEE290FC4CDQ27026443-67DD44A4-4159-433F-B3C0-1FEF8B536687Q27330950-5CE3AFC4-1019-4529-A2EF-C1780161CC19Q27496303-515EC27B-FB6A-462E-A1A7-BE9815A990F8Q28142608-F6B33523-7BEE-46C2-B456-97E05120A0E5Q28165866-7AF9F628-70F2-4926-A4FC-5AD4BB16E76EQ28185785-A68C8EE6-0347-4DF2-B9B7-762BBB7FA224Q28186509-987AAC19-FC7E-4416-8936-B75EBB4CE6A6Q28244400-67816C4C-671A-4956-9A04-71E53951F869Q28246834-EAB4F769-ED96-4209-A708-CA7F777F031DQ28248481-25BE34FB-86E1-49B6-9135-D6FB3AAAEAD7Q28248981-E3152A22-224C-4F67-8285-1BB3A896BBFCQ28262546-559E7E54-75DF-4C1E-8FE9-46D753E348B9Q28272440-7FF98024-6687-4220-8943-7134E4B8F401Q28288737-8E2092AA-7CF1-4A01-9375-3C0B93A98D26Q28305612-D06962D2-FF6D-4A5E-92E3-7DFF75CA677FQ28308242-86A91028-1463-4FB9-AB0F-48DA1B0988FFQ28343961-161BF887-F43D-4CB8-906B-2FE70CCC3EE6Q28345160-E1A9048D-E579-4140-985C-353873983AF1Q28345246-93C8B8E9-8C62-48CE-BF1E-893BDC0650ADQ28345762-79409B6C-E7E3-45B7-AAB2-1C12EA5FED37Q28346449-6B930206-FC8E-4C0C-8931-A77F2AD64E8FQ28346456-9DD8ED05-EF96-4AEA-A3C8-B4A3C2193BFFQ28346701-63C8C280-2161-4573-975B-2EC75F589F12
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Anandamid
@cs
Anandamid
@de
Anandamid
@hu
Anandamid
@nb
Anandamid
@sh
Anandamid
@sr-el
Anandamid
@sv
Anandamide
@it
Anandamide
@nl
Anandamide
@ur
type
label
Anandamid
@cs
Anandamid
@de
Anandamid
@hu
Anandamid
@nb
Anandamid
@sh
Anandamid
@sr-el
Anandamid
@sv
Anandamide
@it
Anandamide
@nl
Anandamide
@ur
altLabel
(5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)-5,8,11,14-eicosatetraenamide
@en
(all-Z)-N-(2-hydroxyethyl)-5,8,11,14-eicosatetraenamide
@en
5,8,11,14-Eicosatetraenoylethanolamide
@en
94421-68-8
@fr
AEA
@cs
AEA
@en
AEA
@he
AEA
@pl
Anandamid
@ru
Anandamide (20.4, N-6)
@en
prefLabel
Anandamid
@cs
Anandamid
@de
Anandamid
@hu
Anandamid
@nb
Anandamid
@sh
Anandamid
@sr-el
Anandamid
@sv
Anandamide
@it
Anandamide
@nl
Anandamide
@ur
P129
P527
P6689
P486
P592
P6366
P646
P661
P662
P665
P683
P129
P1417
topic/anandamide
P1579
P2017
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO